Initial examination of the phenotypes with DIC and fluomicrotubule-stabilizing proteins; however, it is unclear rescence microscopy of a GFP::Histone; GFP::␤-tubulin whether TACC proteins have microtubule-based funcstrain showed that tac-1(RNAi) resulted in a failure of tions distinct from XMAP215. We depleted both the oocyte meiosis, pronuclear migration, and mitotic spin-XMAP215 ortholog ZYG-9 and TAC-1 via dsRNA-medidle positioning of the one-cell embryo ( Figure 1A ). These ated interference (RNAi). We found that tac-1(RNAi) phenotypes are consistent with defects in MTs. The resulted in microtubule-based defects that were very extent and range of phenotypes observed were reminissimilar to zyg-9(RNAi). Furthermore, TAC-1 and ZYG-9 cent of the MT defects observed in zyg-9 mutant embryos are required for long astral microtubules in general
. Therefore, the cytoplasmic environment may also determine the effect that XMAP215 were not significantly different from wild-type. Therefore, the amount of MTs near the centrosome is not members have on MT behavior. If TAC-1 is required for the function of the XMAP215-dramatically affected by the loss of either TAC-1 or ZYG-9, unlike ␥-tubulin for instance, which has a profound effect like protein ZYG-9, then we expect the two proteins to be at the same intracellular location. In order to assess on the ability of centrosomes to nucleate MTs in C. elegans [20] . From these data, we conclude that the the location of the TAC-1 protein, we constructed a GFP::TAC-1 worm strain. Using Nipkow spinning disk broad range of MT-based phenotypes that occurs in both tac-1(RNAi) and zyg-9(RNAi) is best explained by confocal microscopy, we observed GFP fluorescence at the centrosomes early in pronuclear migration, although the shortening of all MTs emanating from the centrosome as a consequence of reduced MT stability. The we could only detect a signal after separation of the centrosomes (Figure 2 ). This is consistent with our re-MT shortening is likely not due to problems with nucleating MTs since we did not detect any decrease in the sults above; neither TAC-1 nor ZYG-9 are required for centrosome separation. The GFP signal at the centroamount of MTs near the centrosomes in either tac-1(RNAi) or zyg-9(RNAi). This contrasts with recent evisomes increased in intensity throughout the cell cycle, as has been reported for ZYG-9 [8, 24] . At metaphase dence implicating XMAP215 in the nucleation of MTs in Xenopus oocyte extracts [21] , and these data may reand early anaphase, we also observed fluorescence at the MT/kinetochore interface (Figure 2 , inset). Anti-TAC-1 flect divergence of the specific activity of the XMAP215 family members. While our data does agree with the antibodies confirmed all patterns observed with the GFP strain ( Figure 3 and data not shown). However, the kinet-MT-stabilizing behavior of XMAP215 and Msps, clearly not all family members share this activity. For instance, ochore staining was not always visible in fixed samples, perhaps due to epitope sensitivity to fixation in this rethe distantly related yeast family member Stu2p has been shown to exhibit MT-destabilizing activity in vitro gion. Together, the location patterns for TAC-1 were highly similar to those previously reported for ZYG-9 [22] . Also, XMAP215 itself does induce depolymerization of GMPCPP-stabilized MTs [23] . In order to explain this based on immunostaining [8] .
Immunolocalization studies in Drosophila showed that apparent contradiction, it has been proposed that XMAP215 proteins may alter the pause state of MTs, efficient localization of Msps to centrosomes relies on D-TACC and vice versa [11, 12] . To test whether TAC-1 in msps embryos, which may account for the difference [11, 12] . is required for the location of ZYG-9 and vice versa, we immunostained embryos after RNAi treatment. When
In contrast to the above experiment, we always observed a significant amount of ZYG-9 at the centro-ZYG-9 was depleted from embryos, we consistently observed a correlated decrease in TAC-1 at the centrosomes when TAC-1 was depleted ( Figure 3B ). Quantification of this signal showed that an average of 22.1% some (Figures 3A and 3E) . In embryos having less than 5% ZYG-9 remaining at centrosomes, we observed less of ZYG-9 was still present at centrosomes having less than 1% TAC-1 (n ϭ 10 centrosomes; Figure 3E ). Therethan 0.5% TAC-1 (n ϭ 3; data not shown). For embryos having more than 5% ZYG-9 (average of 7.6%), TAC-1 fore, some ZYG-9 is capable of locating to the centrosomes in the absence of TAC-1. Western blot analysis was detected at the same or lower levels (average of 7.1%; n ϭ 10 centrosomes; Figure 4E ). This result sugshowed that in tac-1(RNAi) embryos, the ZYG-9 protein is still present at approximately 1/2 of wild-type levels gests that TAC-1 directly depends on ZYG-9 for its centrosomal location. However, Western blot analysis ( Figure 3D ; see the Experimental Procedures). Therefore, differential stabilities of ZYG-9 and TAC-1 may also showed that in zyg-9(RNAi) embryos, the TAC-1 protein levels are also reduced (approximately 1/8 of wild-type contribute to the observed differences in the immunofluorescence experiments described above. In a similar levels; see the Experimental Procedures). Therefore, we are unable to make a strong statement regarding the set of experiments by Le Bot et al. Despite the small size of this TACC family member, it appears that the ability to interact with its XMAP215 counterpart is conserved. This is consistent with experiments in Drosophila that showed that the C-terminal TACC domain (see Figure S1 ) is sufficient to localize to centrosomes and interact with Msps [10, 12] .
Conclusions
Taken together, our results show that ZYG-9 and TAC-1 form a complex that is required for the formation of long microtubules in the early embryo, but our data suggest that this complex is not required for efficient nucleation of microtubules. If this complex is not required for nucleation, why is its predominant location at the centrosome? One possibility is that ZYG-9/TAC-1 binds to and stabilizes the microtubule plus end concomitant with nucleation. While there is no evidence outside of the kinetochore/MT interface for plus end localization of ZYG-9 [8] and TAC-1 (this study), this may be a limitation 
